Mark T. Brown

Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery

Nancy A. Nussmeier, Andrew Whelton, Mark T. Brown et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Medicine, Perioperative Medicine, Surgery +11

Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

Mark T. Brown, Frederick T. Murphy, David Radin et al. · Journal of Pain · 2012 · 196 citations

Medicine, Orthopaedic Surgery, Pharmacotherapy +14

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.

Darell D. Bigner, Mark T. Brown, Allan H. Friedman et al. · Journal of Clinical Oncology · 1998 · 195 citations

Medicine, Nuclear Medicine, Oncology +14

Safety and Efficacy of the Cyclooxygenase-2 Inhibitors Parecoxib and Valdecoxib after Noncardiac Surgery

Nancy A. Nussmeier, Andrew Whelton, Mark T. Brown et al. · Anesthesiology · 2006 · 161 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain

Thomas J. Schnitzer, Evan F. Ekman, Egilius L.H. Spierings et al. · Annals of the Rheumatic Diseases · 2014 · 155 citations

Medicine, Orthopedic Surgery, Pharmacotherapy +17